The presence of multiple subclones within tumors mandates understanding of longitudinal and spatial subclonal dynamics. Resolving the spatial and temporal heterogeneity of subclones with cancer driver events may offer insight into therapy response, tumor evolutionary histories and clinical trial design
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Tumor heterogeneity is believed to be important in tumor progression and its response to therapies. ...
Developments in genomic techniques have provided insight into the remarkable genetic complexity of m...
The presence of multiple subclones within tumors mandates understanding of longitudinal and spatial ...
The presence of multiple subclones within tumors mandates understanding of longitudinal and spatial ...
Precision medicine requires an understanding of cancer genes and mutational processes, as well as an...
Intratumour heterogeneity complicates biomarker discovery and treatment personalization, and pervasi...
Abstract Analysis of spatial and temporal genetic heterogeneity in human cancers has revealed that s...
Emerging evidence suggests that cancer branched evolution may affect biomarker validation, clinical ...
Given the implications of tumor dynamics for precision medicine, there is a need to systematically c...
Background: The advent of rapid and inexpensive sequencing technology allows scientists to decipher ...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Accelerating technological advances have allowed the widespread genomic profiling of tumors. As yet,...
The facts that cancer represents tissues consisting of heterogeneous neoplastic, as well as reactive...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Tumor heterogeneity is believed to be important in tumor progression and its response to therapies. ...
Developments in genomic techniques have provided insight into the remarkable genetic complexity of m...
The presence of multiple subclones within tumors mandates understanding of longitudinal and spatial ...
The presence of multiple subclones within tumors mandates understanding of longitudinal and spatial ...
Precision medicine requires an understanding of cancer genes and mutational processes, as well as an...
Intratumour heterogeneity complicates biomarker discovery and treatment personalization, and pervasi...
Abstract Analysis of spatial and temporal genetic heterogeneity in human cancers has revealed that s...
Emerging evidence suggests that cancer branched evolution may affect biomarker validation, clinical ...
Given the implications of tumor dynamics for precision medicine, there is a need to systematically c...
Background: The advent of rapid and inexpensive sequencing technology allows scientists to decipher ...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Accelerating technological advances have allowed the widespread genomic profiling of tumors. As yet,...
The facts that cancer represents tissues consisting of heterogeneous neoplastic, as well as reactive...
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important ...
Tumor heterogeneity is believed to be important in tumor progression and its response to therapies. ...
Developments in genomic techniques have provided insight into the remarkable genetic complexity of m...